This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Shanghai, Shaanxi highlight merger-review pilot outcomes as China formalizes program

By MLex Staff ( August 7, 2025, 07:40 GMT | Insight) -- Local antitrust regulators in Shanghai and Shaanxi have reported strong operational statistics from China’s entrusted merger-review pilot, as the country moves to institutionalize the program after three years of implementation. In Shanghai, the local regulator said it had reviewed 433 cases under the pilot as of the end of July 2025, roughly 40 percent of the total handled by all five participating provinces. The Shaanxi agency reported an average acceptance time of 11.4 days and an average case completion time of 18.3 days.Local antitrust regulators in Shanghai and Shaanxi have reported strong operational statistics from China’s entrusted merger-review pilot, as the country moves to institutionalize the program after three years of implementation by five provincial agencies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login